Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Target drug programs and medication use evaluation.

Y A Hekster1

  • 1Department of Clinical Pharmacy, University Hospital Nijmegen, The Netherlands.

Pharmacotherapy
|October 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis.

Scandinavian journal of rheumatology·2010
Same author

Pharmacotherapy of epilepsy: state of the art and developments.

Journal of clinical pharmacy and therapeutics·2009
Same author

Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.

Annals of the rheumatic diseases·2008
Same author

Cost-effectiveness of add-on lamotrigine therapy in clinical practice.

Epilepsy research·2005
Same author

[Selective serotonin reuptake inhibitors (SSRI's) are not indicated for children and adolescents with depression].

Nederlands tijdschrift voor geneeskunde·2005
Same author

Effectiveness of lamotrigine in clinical practice: results of a retrospective population-based study.

Epilepsy research·2005
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
Same journal

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same journal

Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients.

Pharmacotherapy·2026
See all related articles

Target drug programs enhance medication use by focusing on problems and optimizing patient care. These initiatives promote the safe and rational use of drugs in society.

Area of Science:

  • Pharmacoeconomics
  • Clinical Pharmacy
  • Health Services Research

Background:

  • Target drug programs and medication use evaluations are crucial for improving drug efficacy and patient outcomes.
  • Focus areas include inappropriate drug use, drug-related problems, and optimizing therapeutic strategies.
  • Evaluating program effects requires assessing economic, clinical, and quality-of-life outcomes.

Purpose of the Study:

  • To outline the objectives and methodologies of target drug programs.
  • To emphasize the importance of comprehensive outcome evaluation in drug use programs.
  • To highlight the necessity of integrating drug and patient data for effective monitoring.

Main Methods:

  • Utilizing the World Health Organization's (WHO) drug classification system (anatomic, therapeutic, chemical).

Related Experiment Videos

  • Monitoring diverse outcomes: economic, clinical quality, quality of life, patient satisfaction, and collaborative practice.
  • Linking drug data with patient data to assess clinical practice impact.

    • Main Results:

    • Target drug programs demonstrably improve appropriate drug utilization.
    • These programs contribute to the safe and rational application of medications.
    • Integrated data monitoring provides a holistic view of program effectiveness.

    Conclusions:

    • Target drug programs are essential for optimizing medication use and enhancing patient care.
    • Comprehensive evaluation, including economic and clinical endpoints, is vital.
    • Linking drug and patient data is key to understanding and improving clinical practice.